BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 7999363)

  • 1. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the intracellular domain of FGF receptor 2IIIb affects contact of the ectodomain with two FGF7 ligands.
    Uematsu F; Jang JH; Kan M; Wang F; Luo Y; McKeehan WL
    Biochem Biophys Res Commun; 2001 May; 283(4):791-7. PubMed ID: 11350054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine box: a determinant of specificity for fibroblast growth factor.
    Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
    Mohammadi M; Olsen SK; Goetz R
    Curr Opin Struct Biol; 2005 Oct; 15(5):506-16. PubMed ID: 16154740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding properties of binary complexes of heparin and immunoglobulin-like modules of FGF receptor 2.
    Uematsu F; Kan M; Wang F; Jang JH; Luo Y; McKeehan WL
    Biochem Biophys Res Commun; 2000 Jun; 272(3):830-6. PubMed ID: 10860838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
    Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
    Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
    Aviezer D; Safran M; Yayon A
    Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X; Tassin J; Berrou E; Bryckaert M; Courtois Y; Mascarelli F
    J Cell Physiol; 1996 Jan; 166(1):170-87. PubMed ID: 8557766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.
    Shi E; Kan M; Xu J; Wang F; Hou J; McKeehan WL
    Mol Cell Biol; 1993 Jul; 13(7):3907-18. PubMed ID: 8321198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
    Pellegrini L; Burke DF; von Delft F; Mulloy B; Blundell TL
    Nature; 2000 Oct; 407(6807):1029-34. PubMed ID: 11069186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.
    Mohammadi M; Dionne CA; Li W; Li N; Spivak T; Honegger AM; Jaye M; Schlessinger J
    Nature; 1992 Aug; 358(6388):681-4. PubMed ID: 1379698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S; Habuchi H; Sugaya N; Kobayashi T; Kimata K
    Glycobiology; 2009 Jun; 19(6):644-54. PubMed ID: 19254961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
    Brown KJ; Hendry IA; Parish CR
    J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF-2 facilitates binding of SH3 domain of PLC-gamma1 to vinculin and SH2 domains to FGF receptor in corneal endothelial cells.
    Park SY; Barron E; Suh PG; Ryu SH; Kay EP
    Mol Vis; 1999 Aug; 5():18. PubMed ID: 10459043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1.
    Larose L; Gish G; Shoelson S; Pawson T
    Oncogene; 1993 Sep; 8(9):2493-9. PubMed ID: 7689724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin.
    Lundin L; Rönnstrand L; Cross M; Hellberg C; Lindahl U; Claesson-Welsh L
    Exp Cell Res; 2003 Jul; 287(1):190-8. PubMed ID: 12799194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.
    Wang F; Kan M; Yan G; Xu J; McKeehan WL
    J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.